Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Diagnosis of PML-RARA-Positive APL 125<br />
2. Rambaldi, A. and Biondi, A. (2002) Acute promyelocytic leukaemia, in <strong>Leukemia</strong><br />
(Henderson, E. S., Lister, T. A., Greaves, M. F., eds.), Saunders, Philadelphia, pp. 529–543.<br />
3. Grimwade, D., Biondi, A., Mozziconacci, M. J., et al. (2000) Characterization of<br />
acute promyelocytic leukemia cases lacking the classic t(15;17): results of the<br />
European Working Party. Groupe Francais de Cytogenetique Hematologique,<br />
Groupe de Francais d’Hematologie Cellulaire, UK Cancer Cytogenetics Group<br />
and BIOMED 1 European Community-Concerted Action “Molecular Cytogenetic<br />
Diagnosis in Haematological Malignancies.” Blood 96,1297–1308.<br />
4. Grignani, F., Fagioli, M., Alcalay, M., et al. (1994) Acute promyelocytic leukemia:<br />
from genetics to treatment. Blood 83, 10–25.<br />
5. Chen, Z., Brand, N. J., Chen, A., et al. (1993) Fusion between a novel Kruppellike<br />
zinc finger gene and the retinoic acid receptor-alpha locus due to a variant<br />
t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J.<br />
12, 1161–1167.<br />
6. Redner, R. L., Rush, E. A., Faas, S., Rudert, W. A., and Corey, S. J. (1996) The<br />
t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosminretinoic<br />
acid receptor fusion. Blood 87, 882–886.<br />
7. Wells, R. A., Catzavelos,]ô., and Kamel-Reid, S. (1997) Fusion of retinoic acid<br />
receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation<br />
in acute promyelocytic leukaemia. Nat. Genet. 17, 109–113.<br />
8. Arnould, C., Philippe, C., Bourdon, V., Grégoire, M. J., Berger, R., and Jonveaux,<br />
P. (1999) The signal transducer and activator of transcription STAT5b gene is a<br />
new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia.<br />
Hum. Mol. Genet. 8, 1741–1749.<br />
9. Lo Coco, F., Diverio, D., Falini, B., Biondi, A., Nervi, C., and Pelicci, P. G. (1999)<br />
Genetic diagnosis and molecular monitoring in the management of acute<br />
promyelocytic leukemia. Blood 94,12–22.<br />
10. Lo Coco, F., Breccia, M., and Diverio, D. (2003) The importance of molecular<br />
monitoring in acute promyelocytic leukaemia. Best Pract. Res. Clin. Haematol.<br />
16, 503–520. Review.<br />
11. Reiter, A., Lengfelder, E., and Grimwade, D. (2004) Pathogenesis, diagnosis and<br />
monitoring of residual disease in acute promyelocytic leukaemia. Acta Haematol.<br />
112, 55–67. Review.<br />
12. van Dongen, J. J., Macintyre, E. A., Gabert, J. A., et al. (1999) Standardized RT-<br />
PCR analysis of fusion gene transcripts from chromosome aberrations in acute<br />
leukemia for detection of minimal residual disease. Report of the BIOMED-1<br />
Concerted Action: investigation of minimal residual disease in acute leukemia.<br />
<strong>Leukemia</strong> 13, 1901–1928.<br />
13. Biondi, A., Rambaldi, A., Pandolfi, P. P., et al. (1992) Molecular monitoring of<br />
the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by<br />
polymerase chain reaction. Blood 80, 492–497.<br />
14. Lo Coco, F., Diverio, D., Avvisati, G., et al. (1999) Therapy of molecular relapse<br />
in acute promyelocytic leucemia. Blood 94, 2225–2229.<br />
15. Chomczynski, P. and Sacchi, N. (1987) Single step method of RNA isolation by<br />
guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159.
Change language